Share: Facebook Twitter LinkedIn
Activity Provided By:

Relias LLC

INFORM: Information Needed for Optimal Regulation of Mycophenolate- A REMS Activity

Access Activity

Overview / Abstract:

Target Audience
The target audience for this initiative includes obstetricians, gynecologists, primary care physicians, physician assistants, nurse practitioners, pharmacists, and care team members involved in the treatment of women across their reproductive lifespan who may have been prescribed mycophenolate products.

Program Overview
Clinicians who work with women of childbearing age who are, or will be, taking mycophenolate must ensure that their patients receive appropriate counseling about the teratogenic effects of mycophenolate and the need for use of contraceptives during the time they are taking the drug. This interactive course is based on the FDA’s Mycophenolate REMS Education Blueprint.

Learning Objectives
Upon completion of this activity, participants should be better able to:

The increased risks of first trimester pregnancy loss and congenital malformations associated with mycophenolate
Importance of educating women of reproductive potential about the increased risk of first trimester pregnancy loss and congenital malformations associated with exposure to mycophenolate during pregnancy
Importance of prescribers providing or facilitating patient education about pregnancy prevention and planning, including acceptable methods of contraception during mycophenolate treatment
When treating a pregnant patient or a patient who is considering pregnancy, consider alternative immunosuppressants with less potential for embryofetal toxicity
Importance of reporting to the Mycophenolate Pregnancy Registry any pregnancies that occur during mycophenolate treatment or within 6 weeks following discontinuation of treatment
Importance of encouraging pregnant patients to participate in the Mycophenolate Pregnancy Registry


May 24, 2024


Physician CME



Credits / Hours




Presenters / Authors / Faculty

Emmie Strassberg, DO
A Maternal-Fetal Medicine physician practicing in Virginia and West Virginia.

Barrett Crowther, PharmD
Team Lead for Ambulatory Care Solid Organ Transplant and Hepatology Pharmacy Services and PGY2 Solid Organ Transplantation Pharmacy Residency Program Director at University of Colorado Health.

Vivek Gupta, MD
A Maternal-Fetal Medicine physician practicing in Virginia and West Virginia.

Sponsors / Supporters / Grant Providers

American College of Osteopathic Obstetricians and Gynecologists (ACOOG) / The France Foundation / Mycophenolate REMS Group

Keywords / Search Terms

Relias LLC Obstetrics & Gynecology, Primary Care, Pregnancy, Childbirth, Womens Health, Reproductive Health Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map